Neoleukin Therapeutics Inc (NLTX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -27.642 | -37.916 | -33.611 | -61.825 | -18.614 | -32.475 | -41.228 | -21.456 |
Return on Equity (%) | -29.241 | -41.209 | -36.821 | -64.79 | -19.992 | -36.334 | -48.531 | -25.908 |
Return on Invested Capital (%) | -45.732 | -52.981 | -38.172 | -66.054 | -20.255 | -36.621 | -50.289 | -39.938 |
Operating Margin (%) | N/A | N/A | -126.324 | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -126.34 | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 4.892 | 3.339 | 2.448 | 3.197 | 3.948 | 2.937 | 1.933 | 11.967 |
Earnings Per Share | -1.251 | -1.694 | -1.064 | -1.573 | -0.688 | -1.249 | -1.18 | -2.336 |
Cash Per Share | 1.092 | 1.757 | 2.592 | 3.242 | 3.983 | 2.931 | 0.776 | 9.534 |
Working Capital Per Share | 3.178 | 3.304 | 2.444 | 3.145 | 3.861 | 2.785 | 1.805 | 11.41 |
Operating Profit Per Share | N/A | N/A | 0.842 | N/A | 0.162 | N/A | N/A | N/A |
EBIT Per Share | -1.251 | -1.694 | -1.064 | -1.573 | -0.688 | -1.249 | -1.18 | -2.336 |
EBITDA Per Share | -1.251 | -1.694 | -1.064 | -1.573 | -0.688 | -1.249 | -1.18 | -2.336 |
Free Cash Flow Per Share | -1.227 | -1.678 | -1.062 | -1.561 | -0.659 | -1.208 | -1.189 | -2.528 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 23,42M | 23,47M | 23,54M | 38M | 42,2M | 42,46M | 42,65M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 42,65M | N/A | N/A | N/A | N/A | N/A | N/A | 13,01M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 40,7M |
Ratio cours/bénéfice | -7,45 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,83 |
Ratio prix/valeur comptable | 1,45 |
Rendement de dividende | - |
Actions en circulation | 11,66M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales